Integrated Epigenetic Biomarkers in cell free circulating DNA as A Robust Classifier for Pancreatic Cancer

cfDNA 5hmC and 5mC data of PDAC and healthy samples

Summary

The high lethal rate of pancreatic cancer is partly owing to lack of efficient biomarkers for screening and early diagnosis. We attempted to develop effective and non-invasive methods using 5mC and 5hmC markers from circulating cell-free DNA (cfDNA) for detection of Pancreatic Ductal Adenocarcinoma (PDAC).

View details »

Data Access

5hmC and 5mC cfDNA data of PDAC and healthy samples could be accessed through data portal.

View details »